Three months after admission, after controlling for blood pressure with angiotensin-converting enzyme (ACE) inhibitors, the patient continued with asthenia but without evidence of hemolytic anemia and renal failure (Cr 0.8 mg/dL without proteinuria and hematuria). This evidence concerns the gene ACE and asthenia.